Calithera Biosciences Inc. (CALA) OTC MARKETS
$0.04 - (-)
Market Cap: $194900
As of 04/17/24 12:00 AM EDT. Market closed.
Calithera Biosciences Inc. (CALA)
OTC MARKETS
$0.04
- (-)
Market Cap: $194900
As of 04/17/24 12:00 AM EDT. Market closed.
calithera is focused on discovering and developing first-in-class small molecule drugs that slow tumor growth through controlling key metabolic pathways in the tumor and immune cells. tumor metabolism and tumor immunology are promising new interrelated fields for cancer drug discovery. recent clinical successes have demonstrated the potential to slow abnormal cell growth and create fundamentally ... read more
calithera is focused on discovering and developing first-in-class small molecule drugs that slow tumor growth through controlling key metabolic pathways in the tumor and immune cells. tumor metabolism and tumor immunology are promising new interrelated fields for cancer drug discovery. recent clinical successes have demonstrated the potential to slow abnormal cell growth and create fundamentally new therapies for cancer patients. our investigational onco-metabolism medicines take advantage of the different metabolic requirements of tumor cells and cancer-fighting immune cells. calithera’s discovery and development efforts are focused on solid tumors for which new treatments are urgently needed. we are currently developing our lead candidate in phase 2 trials in patients with renal cell carcinoma, triple negative breast cancer. targeting cancer, differently. our onco-metabolism approach brings an enhanced perspective to cancer. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
PAKIANATHAN DEEPIKA | Director | Jan 27, 2023 | Sale | $0.39 | 1,172 | 452 | 0 | Jan 31, 2023, 07:04 PM |
PAKIANATHAN DEEPIKA | Director | Jan 27, 2023 | Sale | $0.39 | 120,161 | 46,358 | 0 | Jan 31, 2023, 07:04 PM |
Sjogren Eric | SR. VP, DRUG DISCOVERY | Jan 23, 2023 | Option Exercise | $0.45 | 279 | 124 | 8,467 | Jan 25, 2023, 04:00 PM |
Kuriakose Emil | CHIEF MEDICAL OFFICER | Jan 23, 2023 | Option Exercise | $0.45 | 79 | 35 | 3,539 | Jan 25, 2023, 04:00 PM |
Molineaux Susan | PRESIDENT & CEO | Jan 23, 2023 | Option Exercise | $0.45 | 526 | 235 | 27,859 | Jan 25, 2023, 04:00 PM |
Wong Stephanie | See Remarks | Jan 23, 2023 | Option Exercise | $0.45 | 317 | 141 | 6,287 | Jan 25, 2023, 04:00 PM |
Molineaux Christopher | SR. VP, DEVELOPMENT | Jan 23, 2023 | Option Exercise | $0.45 | 217 | 97 | 27,859 | Jan 25, 2023, 04:00 PM |
Parlati Francesco | SR. VP, RESEARCH | Jan 21, 2022 | Option Exercise | $0.49 | 4,794 | 2,356 | 140,998 | Jan 25, 2022, 04:05 PM |
Wong Stephanie | See Remarks | Jan 21, 2022 | Option Exercise | $0.49 | 5,586 | 2,746 | 132,085 | Jan 25, 2022, 04:05 PM |
Sjogren Eric | SR. VP, DRUG DISCOVERY | Jan 21, 2022 | Option Exercise | $0.49 | 4,794 | 2,356 | 172,434 | Jan 25, 2022, 04:05 PM |
Parlati Francesco | SR. VP, RESEARCH | Jan 04, 2022 | Option Exercise | $0.66 | 18,077 | 11,938 | 145,792 | Jan 06, 2022, 09:00 PM |
Kuriakose Emil | CHIEF MEDICAL OFFICER | Jan 04, 2022 | Option Exercise | $0.66 | 3,855 | 2,546 | 68,035 | Jan 06, 2022, 09:00 PM |
Sjogren Eric | SR. VP, DRUG DISCOVERY | Jan 04, 2022 | Option Exercise | $0.66 | 18,077 | 11,938 | 177,228 | Jan 06, 2022, 09:00 PM |
Wong Stephanie | See Remarks | Jan 04, 2022 | Option Exercise | $0.66 | 18,077 | 11,938 | 137,671 | Jan 06, 2022, 09:00 PM |
Orford Keith | Director | Nov 11, 2021 | Sale | $0.88 | 48,190 | 42,407 | 66,094 | Nov 12, 2021, 05:30 PM |
Orford Keith | Director | Nov 10, 2021 | Sale | $0.86 | 30,000 | 25,695 | 114,284 | Nov 12, 2021, 05:30 PM |
Molineaux Susan | PRESIDENT & CEO | Nov 10, 2021 | Buy | $0.85 | 100,000 | 84,670 | 557,188 | Nov 10, 2021, 07:34 PM |
DRACHMAN JONATHAN G | Director | Nov 10, 2021 | Buy | $0.86 | 200,000 | 171,900 | 200,000 | Nov 10, 2021, 07:31 PM |
Molineaux Christopher | SR. VP, DEVELOPMENT | Nov 10, 2021 | Buy | $0.85 | 100,000 | 84,670 | 557,188 | Nov 10, 2021, 07:28 PM |
Orford Keith | Director | Nov 09, 2021 | Sale | $0.84 | 51,810 | 43,520 | 144,284 | Nov 09, 2021, 07:39 PM |
Sjogren Eric | SR. VP, DRUG DISCOVERY | Nov 08, 2021 | Option Exercise | $0.87 | 15,566 | 13,542 | 195,305 | Nov 09, 2021, 07:35 PM |
Wong Stephanie | See Remarks | Nov 08, 2021 | Option Exercise | $0.87 | 15,566 | 13,542 | 155,748 | Nov 09, 2021, 07:34 PM |
Kuriakose Emil | CHIEF MEDICAL OFFICER | Nov 08, 2021 | Option Exercise | $0.87 | 3,077 | 2,677 | 69,390 | Nov 09, 2021, 07:32 PM |
Parlati Francesco | SR. VP, RESEARCH | Nov 08, 2021 | Option Exercise | $0.87 | 15,566 | 13,542 | 163,869 | Nov 09, 2021, 07:28 PM |
Sjogren Eric | SR. VP, DRUG DISCOVERY | Oct 28, 2021 | Option Exercise | $1.89 | 45,965 | 86,874 | 180,871 | Oct 29, 2021, 06:55 PM |
Wong Stephanie | See Remarks | Oct 28, 2021 | Option Exercise | $1.89 | 45,965 | 86,874 | 141,314 | Oct 29, 2021, 06:50 PM |
Parlati Francesco | SR. VP, RESEARCH | Oct 28, 2021 | Option Exercise | $1.89 | 45,965 | 86,874 | 149,435 | Oct 29, 2021, 06:47 PM |
Orford Keith | Chief Medical Officer | Dec 16, 2020 | Sale | $6.00 | 2,447 | 14,682 | 11,094 | Dec 18, 2020, 05:00 PM |
BVF PARTNERS L P/IL | 10% Owner | May 21, 2020 | Sale | $6.00 | 2,283,598 | 13,701,588 | 3,712,340 | May 26, 2020, 05:52 PM |
Wong Stephanie | SR. VP, FINANCE & SECRETARY | Apr 15, 2020 | Sale | $8.00 | 5,000 | 40,000 | 30,082 | Apr 17, 2020, 04:05 PM |
Orford Keith | Chief Medical Officer | Feb 20, 2020 | Sale | $8.00 | 3,021 | 24,168 | 8,541 | Feb 24, 2020, 04:05 PM |
Orford Keith | Chief Medical Officer | Dec 23, 2019 | Sale | $6.00 | 3,021 | 18,126 | 11,562 | Dec 26, 2019, 04:01 PM |
BVF PARTNERS L P/IL | 10% Owner | Nov 20, 2019 | Buy | $3.91 | 191,954 | 750,847 | 4,739,356 | Nov 22, 2019, 07:53 PM |
BVF PARTNERS L P/IL | 10% Owner | Nov 14, 2019 | Buy | $3.37 | 128,488 | 433,005 | 4,640,838 | Nov 18, 2019, 06:38 PM |
BVF PARTNERS L P/IL | 10% Owner | Oct 29, 2019 | Buy | $2.60 | 1,598,977 | 4,157,340 | 4,160,751 | Oct 31, 2019, 06:27 PM |
BVF PARTNERS L P/IL | 10% Owner | Oct 30, 2019 | Buy | $2.70 | 797,508 | 2,153,272 | 4,569,343 | Oct 31, 2019, 06:27 PM |
Molineaux Christopher | SR. VP, DEVELOPMENT | Jun 25, 2019 | Buy | $3.88 | 51,600 | 200,208 | 457,188 | Jun 27, 2019, 04:06 PM |
Molineaux Susan | PRESIDENT AND CEO | Jun 25, 2019 | Buy | $3.88 | 51,600 | 200,208 | 457,188 | Jun 27, 2019, 04:05 PM |
Sjogren Eric | SR. VP, DRUG DISCOVERY | Jun 24, 2019 | Option Exercise | $0.96 | 21,739 | 20,869 | 72,057 | Jun 26, 2019, 04:05 PM |
Wong Stephanie | SR. VP, FINANCE & SECRETARY | Jun 19, 2019 | Option Exercise | $2.64 | 10,000 | 26,400 | 31,751 | Jun 21, 2019, 04:05 PM |
Parlati Francesco | VP, RESEARCH | Jun 17, 2019 | Option Exercise | $2.64 | 6,246 | 16,489 | 42,201 | Jun 19, 2019, 04:06 PM |
Orford Keith | Chief Medical Officer | Jun 17, 2019 | Sale | $6.00 | 417 | 2,502 | 12,083 | Jun 19, 2019, 04:05 PM |
Orford Keith | Chief Medical Officer | May 22, 2019 | Sale | $6.00 | 416 | 2,496 | 10,000 | May 24, 2019, 04:05 PM |
Orford Keith | Chief Medical Officer | Apr 15, 2019 | Sale | $6.33 | 416 | 2,633 | 10,416 | Apr 17, 2019, 04:05 PM |
Orford Keith | Chief Medical Officer | Mar 15, 2019 | Sale | $6.43 | 417 | 2,681 | 10,832 | Mar 19, 2019, 04:05 PM |
Orford Keith | Chief Medical Officer | Mar 11, 2019 | Sale | $6.00 | 1,565 | 9,390 | 11,249 | Mar 13, 2019, 04:10 PM |
Orford Keith | SR. VP, CLINICAL DEVELOPMENT | Oct 15, 2018 | Sale | $6.05 | 313 | 1,894 | 10,314 | Oct 17, 2018, 05:00 PM |
Orford Keith | SR. VP, CLINICAL DEVELOPMENT | Oct 11, 2018 | Sale | $6.00 | 1,252 | 7,512 | 10,627 | Oct 15, 2018, 05:00 PM |
Sjogren Eric | SR. VP, DRUG DISCOVERY | Apr 03, 2018 | Option Exercise | $0.48 | 16,810 | 8,069 | 42,818 | Apr 05, 2018, 04:06 PM |
Molineaux Susan | PRESIDENT AND CEO | Mar 02, 2018 | Option Exercise | $2.64 | 26,992 | 71,259 | 44,860 | Mar 06, 2018, 04:12 PM |
Parlati Francesco | VP, RESEARCH | Feb 20, 2018 | Option Exercise | $0.96 | 5,095 | 4,891 | 28,455 | Mar 06, 2018, 04:11 PM |
Molineaux Christopher | SR. VP, DEVELOPMENT | Mar 02, 2018 | Option Exercise | $2.64 | 6,798 | 17,947 | 21,000 | Mar 06, 2018, 04:08 PM |
Wong Stephanie | SR VP, FINANCE AND SECRETARY | Feb 23, 2018 | Option Exercise | $2.64 | 10,000 | 26,400 | 15,000 | Feb 27, 2018, 07:26 PM |
Parlati Francesco | VP, RESEARCH | Feb 20, 2018 | Option Exercise | $0.96 | 5,095 | 4,891 | 20,488 | Feb 22, 2018, 04:05 PM |
Molineaux Susan | PRESIDENT AND CEO | Dec 05, 2017 | Option Exercise | $1.65 | 12,868 | 21,257 | 15,368 | Dec 06, 2017, 04:05 PM |
Molineaux Christopher | SR. VP, DEVELOPMENT | Dec 05, 2017 | Option Exercise | $1.45 | 9,202 | 13,370 | 11,702 | Dec 06, 2017, 04:05 PM |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 10% Owner | Sep 28, 2017 | Sale | $15.50 | 38,000 | 589,000 | 3,546,873 | Sep 28, 2017, 04:10 PM |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 10% Owner | Sep 27, 2017 | Sale | $15.59 | 186,000 | 2,899,740 | 3,584,873 | Sep 28, 2017, 04:10 PM |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 10% Owner | Sep 26, 2017 | Sale | $15.68 | 352,000 | 5,519,360 | 3,770,873 | Sep 28, 2017, 04:10 PM |
Wong Stephanie | VP, FINANCE AND SECRETARY | Jul 17, 2017 | Sale | $18.41 | 3,552 | 65,385 | 10,550 | Jul 19, 2017, 04:06 PM |
Orford Keith | SR. VP, CLINICAL DEVELOPMENT | Jul 17, 2017 | Sale | $18.31 | 2,120 | 38,823 | 6,879 | Jul 19, 2017, 04:05 PM |
Hecht Curtis | SVP, BUS. & CORP. DEVELOPMENT | Jul 06, 2017 | Sale | $18.00 | 700 | 12,600 | 15,940 | Jul 07, 2017, 04:07 PM |
Hecht Curtis | SVP, BUS. & CORP. DEVELOPMENT | May 19, 2017 | Sale | $16.00 | 650 | 10,400 | 14,910 | May 23, 2017, 04:05 PM |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 10% Owner | Mar 22, 2017 | Buy | $10.25 | 487,804 | 4,999,991 | 4,122,873 | Mar 24, 2017, 10:00 AM |
Hecht Curtis | SVP, BUS. & CORP. DEVELOPMENT | Mar 13, 2017 | Sale | $14.00 | 600 | 8,400 | 15,560 | Mar 15, 2017, 04:05 PM |
Hecht Curtis | See Remarks | Mar 02, 2017 | Sale | $12.00 | 550 | 6,600 | 16,160 | Mar 06, 2017, 04:05 PM |
Molineaux Susan | PRESIDENT AND CEO | Dec 19, 2016 | Option Exercise | $2.16 | 21,933 | 47,309 | 23,810 | Dec 20, 2016, 09:00 AM |
Molineaux Christopher | SR. VP, DEVELOPMENT | Dec 19, 2016 | Option Exercise | $1.74 | 10,167 | 17,739 | 12,044 | Dec 20, 2016, 09:00 AM |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 10% Owner | Nov 16, 2016 | Buy | $3.15 | 500,000 | 1,575,000 | 3,635,069 | Nov 17, 2016, 05:07 PM |
Molineaux Susan | PRESIDENT AND CEO | Jul 20, 2016 | Option Exercise | $1.81 | 29,385 | 53,218 | 31,885 | Jul 21, 2016, 07:30 AM |
Molineaux Christopher | SR. VP, DEVELOPMENT | Jul 20, 2016 | Option Exercise | $1.61 | 12,335 | 19,820 | 14,835 | Jul 21, 2016, 07:30 AM |
Bennett Mark K | SR. VP, RESEARCH | Dec 29, 2015 | Option Exercise | $1.60 | 10,413 | 16,617 | 10,413 | Dec 31, 2015, 03:24 PM |
Molineaux Susan | PRESIDENT AND CEO | Dec 21, 2015 | Option Exercise | $1.49 | 27,825 | 41,525 | 109,112 | Dec 23, 2015, 07:13 PM |
Molineaux Christopher | SR. VP, DEVELOPMENT | Dec 21, 2015 | Option Exercise | $1.74 | 10,167 | 17,739 | 39,542 | Dec 23, 2015, 07:10 PM |
Hecht Curtis | VP, BUS. & CORP. DEVELOPMENT | Nov 16, 2015 | Sale | $6.58 | 970 | 6,385 | 8,625 | Nov 18, 2015, 07:51 PM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sep 23, 2015 | Buy | $6.07 | 40,168 | 243,768 | 3,135,069 | Sep 24, 2015, 04:43 PM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sep 22, 2015 | Buy | $6.00 | 66,800 | 400,880 | 3,094,901 | Sep 24, 2015, 04:43 PM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sep 04, 2015 | Buy | $5.95 | 2,300 | 13,685 | 3,028,101 | Sep 08, 2015, 05:05 PM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sep 03, 2015 | Buy | $5.93 | 88,000 | 521,840 | 3,025,801 | Sep 08, 2015, 05:05 PM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Aug 27, 2015 | Buy | $5.35 | 97,168 | 520,207 | 2,895,101 | Aug 28, 2015, 05:46 PM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Aug 26, 2015 | Buy | $4.65 | 32,258 | 150,010 | 2,797,933 | Aug 28, 2015, 05:46 PM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Aug 28, 2015 | Buy | $5.57 | 42,700 | 237,645 | 2,937,801 | Aug 28, 2015, 05:46 PM |
Hecht Curtis | VP, BUS. & CORP. DEVELOPMENT | Aug 20, 2015 | Option Exercise | $2.64 | 2,000 | 5,280 | 8,625 | Aug 24, 2015, 05:18 PM |
Waddill William D. | SR. VP & CFO | Jul 14, 2015 | Option Exercise | $2.64 | 13,125 | 34,650 | 15,625 | Jul 16, 2015, 05:41 PM |
Molineaux Susan | PRESIDENT AND CEO | Jul 13, 2015 | Option Exercise | $1.44 | 76,287 | 109,890 | 78,787 | Jul 15, 2015, 07:52 PM |
Molineaux Christopher | SR. VP, DEVELOPMENT | Jul 13, 2015 | Option Exercise | $1.67 | 24,375 | 40,684 | 26,875 | Jul 15, 2015, 07:49 PM |
Bennett Mark K | SR. VP, RESEARCH | Jul 08, 2015 | Option Exercise | $1.53 | 18,365 | 28,174 | 19,501 | Jul 10, 2015, 07:08 PM |
Waddill William D. | SENIOR VP & CFO | Dec 16, 2014 | Option Exercise | $3.43 | 6,797 | 23,284 | 16,172 | Dec 18, 2014, 05:19 PM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Oct 15, 2014 | Buy | $6.95 | 38,000 | 264,250 | 2,765,675 | Oct 15, 2014, 07:51 PM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Oct 14, 2014 | Buy | $7.00 | 55,000 | 384,750 | 2,727,375 | Oct 15, 2014, 07:51 PM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Oct 13, 2014 | Buy | $6.94 | 88,700 | 615,578 | 2,672,375 | Oct 15, 2014, 07:51 PM |
Delphi Management Partners VIII, L.L.C. | 10% Owner | Oct 07, 2014 | Buy | $10.00 | 4,835 | 48,350 | 23,464 | Oct 09, 2014, 08:44 PM |
Delphi Management Partners VIII, L.L.C. | 10% Owner | Oct 07, 2014 | Buy | $10.00 | 495,165 | 4,951,650 | 2,403,238 | Oct 09, 2014, 08:44 PM |
PAKIANATHAN DEEPIKA | Director | Oct 07, 2014 | Buy | $10.00 | 495,165 | 4,951,650 | 2,403,238 | Oct 09, 2014, 04:49 PM |
PAKIANATHAN DEEPIKA | Director | Oct 07, 2014 | Buy | $10.00 | 4,835 | 48,350 | 23,464 | Oct 09, 2014, 04:49 PM |
Advanced Technology Ventures VIII LP | 10% Owner | Oct 07, 2014 | Buy | $10.00 | 300,000 | 3,000,000 | 2,110,082 | Oct 09, 2014, 04:45 PM |
MORGENTHALER VENTURE PARTNERS IX LP | 10% Owner | Oct 07, 2014 | Option Exercise | $10.00 | 1,811,915 | 18,119,150 | 1,811,915 | Oct 09, 2014, 04:43 PM |
MORGENTHALER VENTURE PARTNERS IX LP | 10% Owner | Oct 07, 2014 | Buy | $10.00 | 350,000 | 3,500,000 | 2,161,915 | Oct 09, 2014, 04:43 PM |
Christoffersen Ralph E | Director | Oct 07, 2014 | Buy | $10.00 | 350,000 | 3,500,000 | 2,161,915 | Oct 09, 2014, 04:41 PM |
George Jean | Director | Oct 07, 2014 | Buy | $10.00 | 300,000 | 3,000,000 | 2,110,082 | Oct 09, 2014, 04:40 PM |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Oct 01, 2014 | Buy | $10.00 | 800,000 | 8,000,000 | 2,583,675 | Oct 03, 2014, 12:25 PM |
Owner | Relationship | Date | Value($) |
PAKIANATHAN DEEPIKA | Director | 01/27/2023 | 452 |
PAKIANATHAN DEEPIKA | Director | 01/27/2023 | 46,358 |
Sjogren Eric | SR. VP, DRUG DISCOVERY | 01/23/2023 | 124 |
Kuriakose Emil | CHIEF MEDICAL OFFICER | 01/23/2023 | 35 |
Molineaux Susan | PRESIDENT & CEO | 01/23/2023 | 235 |
Wong Stephanie | See Remarks | 01/23/2023 | 141 |
Molineaux Christopher | SR. VP, DEVELOPMENT | 01/23/2023 | 97 |
Parlati Francesco | SR. VP, RESEARCH | 01/21/2022 | 2,356 |
Wong Stephanie | See Remarks | 01/21/2022 | 2,746 |
Sjogren Eric | SR. VP, DRUG DISCOVERY | 01/21/2022 | 2,356 |
Parlati Francesco | SR. VP, RESEARCH | 01/04/2022 | 11,938 |
Kuriakose Emil | CHIEF MEDICAL OFFICER | 01/04/2022 | 2,546 |
Sjogren Eric | SR. VP, DRUG DISCOVERY | 01/04/2022 | 11,938 |
Wong Stephanie | See Remarks | 01/04/2022 | 11,938 |
Orford Keith | Director | 11/11/2021 | 42,407 |
Orford Keith | Director | 11/10/2021 | 25,695 |
Molineaux Susan | PRESIDENT & CEO | 11/10/2021 | 84,670 |
DRACHMAN JONATHAN G | Director | 11/10/2021 | 171,900 |
Molineaux Christopher | SR. VP, DEVELOPMENT | 11/10/2021 | 84,670 |
Orford Keith | Director | 11/09/2021 | 43,520 |
Sjogren Eric | SR. VP, DRUG DISCOVERY | 11/08/2021 | 13,542 |
Wong Stephanie | See Remarks | 11/08/2021 | 13,542 |
Kuriakose Emil | CHIEF MEDICAL OFFICER | 11/08/2021 | 2,677 |
Parlati Francesco | SR. VP, RESEARCH | 11/08/2021 | 13,542 |
Sjogren Eric | SR. VP, DRUG DISCOVERY | 10/28/2021 | 86,874 |
Wong Stephanie | See Remarks | 10/28/2021 | 86,874 |
Parlati Francesco | SR. VP, RESEARCH | 10/28/2021 | 86,874 |
Orford Keith | Chief Medical Officer | 12/16/2020 | 14,682 |
BVF PARTNERS L P/IL | 10% Owner | 05/21/2020 | 13,701,588 |
Wong Stephanie | SR. VP, FINANCE & SECRETARY | 04/15/2020 | 40,000 |
Orford Keith | Chief Medical Officer | 02/20/2020 | 24,168 |
Orford Keith | Chief Medical Officer | 12/23/2019 | 18,126 |
BVF PARTNERS L P/IL | 10% Owner | 11/20/2019 | 750,847 |
BVF PARTNERS L P/IL | 10% Owner | 11/14/2019 | 433,005 |
BVF PARTNERS L P/IL | 10% Owner | 10/29/2019 | 4,157,340 |
BVF PARTNERS L P/IL | 10% Owner | 10/30/2019 | 2,153,272 |
Molineaux Christopher | SR. VP, DEVELOPMENT | 06/25/2019 | 200,208 |
Molineaux Susan | PRESIDENT AND CEO | 06/25/2019 | 200,208 |
Sjogren Eric | SR. VP, DRUG DISCOVERY | 06/24/2019 | 20,869 |
Wong Stephanie | SR. VP, FINANCE & SECRETARY | 06/19/2019 | 26,400 |
Parlati Francesco | VP, RESEARCH | 06/17/2019 | 16,489 |
Orford Keith | Chief Medical Officer | 06/17/2019 | 2,502 |
Orford Keith | Chief Medical Officer | 05/22/2019 | 2,496 |
Orford Keith | Chief Medical Officer | 04/15/2019 | 2,633 |
Orford Keith | Chief Medical Officer | 03/15/2019 | 2,681 |
Orford Keith | Chief Medical Officer | 03/11/2019 | 9,390 |
Orford Keith | SR. VP, CLINICAL DEVELOPMENT | 10/15/2018 | 1,894 |
Orford Keith | SR. VP, CLINICAL DEVELOPMENT | 10/11/2018 | 7,512 |
Sjogren Eric | SR. VP, DRUG DISCOVERY | 04/03/2018 | 8,069 |
Molineaux Susan | PRESIDENT AND CEO | 03/02/2018 | 71,259 |
Parlati Francesco | VP, RESEARCH | 02/20/2018 | 4,891 |
Molineaux Christopher | SR. VP, DEVELOPMENT | 03/02/2018 | 17,947 |
Wong Stephanie | SR VP, FINANCE AND SECRETARY | 02/23/2018 | 26,400 |
Parlati Francesco | VP, RESEARCH | 02/20/2018 | 4,891 |
Molineaux Susan | PRESIDENT AND CEO | 12/05/2017 | 21,257 |
Molineaux Christopher | SR. VP, DEVELOPMENT | 12/05/2017 | 13,370 |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 10% Owner | 09/28/2017 | 589,000 |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 10% Owner | 09/27/2017 | 2,899,740 |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 10% Owner | 09/26/2017 | 5,519,360 |
Wong Stephanie | VP, FINANCE AND SECRETARY | 07/17/2017 | 65,385 |
Orford Keith | SR. VP, CLINICAL DEVELOPMENT | 07/17/2017 | 38,823 |
Hecht Curtis | SVP, BUS. & CORP. DEVELOPMENT | 07/06/2017 | 12,600 |
Hecht Curtis | SVP, BUS. & CORP. DEVELOPMENT | 05/19/2017 | 10,400 |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 10% Owner | 03/22/2017 | 4,999,991 |
Hecht Curtis | SVP, BUS. & CORP. DEVELOPMENT | 03/13/2017 | 8,400 |
Hecht Curtis | See Remarks | 03/02/2017 | 6,600 |
Molineaux Susan | PRESIDENT AND CEO | 12/19/2016 | 47,309 |
Molineaux Christopher | SR. VP, DEVELOPMENT | 12/19/2016 | 17,739 |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 10% Owner | 11/16/2016 | 1,575,000 |
Molineaux Susan | PRESIDENT AND CEO | 07/20/2016 | 53,218 |
Molineaux Christopher | SR. VP, DEVELOPMENT | 07/20/2016 | 19,820 |
Bennett Mark K | SR. VP, RESEARCH | 12/29/2015 | 16,617 |
Molineaux Susan | PRESIDENT AND CEO | 12/21/2015 | 41,525 |
Molineaux Christopher | SR. VP, DEVELOPMENT | 12/21/2015 | 17,739 |
Hecht Curtis | VP, BUS. & CORP. DEVELOPMENT | 11/16/2015 | 6,385 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 09/23/2015 | 243,768 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 09/22/2015 | 400,880 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 09/04/2015 | 13,685 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 09/03/2015 | 521,840 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 08/27/2015 | 520,207 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 08/26/2015 | 150,010 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 08/28/2015 | 237,645 |
Hecht Curtis | VP, BUS. & CORP. DEVELOPMENT | 08/20/2015 | 5,280 |
Waddill William D. | SR. VP & CFO | 07/14/2015 | 34,650 |
Molineaux Susan | PRESIDENT AND CEO | 07/13/2015 | 109,890 |
Molineaux Christopher | SR. VP, DEVELOPMENT | 07/13/2015 | 40,684 |
Bennett Mark K | SR. VP, RESEARCH | 07/08/2015 | 28,174 |
Waddill William D. | SENIOR VP & CFO | 12/16/2014 | 23,284 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 10/15/2014 | 264,250 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 10/14/2014 | 384,750 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 10/13/2014 | 615,578 |
Delphi Management Partners VIII, L.L.C. | 10% Owner | 10/07/2014 | 48,350 |
Delphi Management Partners VIII, L.L.C. | 10% Owner | 10/07/2014 | 4,951,650 |
PAKIANATHAN DEEPIKA | Director | 10/07/2014 | 4,951,650 |
PAKIANATHAN DEEPIKA | Director | 10/07/2014 | 48,350 |
Advanced Technology Ventures VIII LP | 10% Owner | 10/07/2014 | 3,000,000 |
MORGENTHALER VENTURE PARTNERS IX LP | 10% Owner | 10/07/2014 | 18,119,150 |
MORGENTHALER VENTURE PARTNERS IX LP | 10% Owner | 10/07/2014 | 3,500,000 |
Christoffersen Ralph E | Director | 10/07/2014 | 3,500,000 |
George Jean | Director | 10/07/2014 | 3,000,000 |
ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | 10/01/2014 | 8,000,000 |